Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tyrosine kinase inhibitors for cancer therapy disclosed by Merck KGaA

Feb. 17, 2010

TopoTarget discloses novel NMPRTase inhibitors

Feb. 17, 2010

Genentech identifies new Janus kinase inhibitors

Feb. 16, 2010

Millennium Pharmaceuticals patents novel proteasome inhibitors

Feb. 16, 2010

Debiopharm's Clinical Trial Application for Debio-0932 approved in France

Feb. 16, 2010

Oxigene presents update on development of Zybrestat

Feb. 16, 2010

YM BioSciences presents CYT-387 and CYT-997 data

Feb. 15, 2010

Genta initiates phase II tesetaxel trial in patients with advanced melanoma

Feb. 15, 2010

Janus kinase inhibitors identified by Merck & Co.

Feb. 15, 2010

Tyrogenex presents protein kinase inhibitors for cancer therapy

Feb. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...